CHINA PHARMACEUTICAL GROUP CORPORATION LIMITED

CSPC Pharmaceutical Group Limited (CSPC) (Stock code: 1093.HK) is a leading pharmaceutical group in China. The company has been listed on the Main Board of the Hong Kong Stock Exchange since 1994 and is a constituent stock of the Hang Seng Index (since 2018), Hang Seng Composite Index, Hang Seng Healthcare Index, Hang Seng SCHK Mainland China Healthcare Index, Hang Seng Stock Connect Hong Kong Index, Hang Seng China (Hong Kong-listed) 100 Index and Hang Seng China Enterprises Index. CSPC focuses on two business segments, finished drugs and bulk drugs, with innovative drugs as the core development strategy. CSPC has a strong product portfolio in the therapeutic areas of nervous system disease, oncology, anti-infective and cardiovascular disease. Bulk drug products include vitamin C, antibiotics and caffeine series. CSPC's manufacturing facilities are mainly located in Shijiazhuang City, Hebei Province, China. CSPC has an international R&D team with R&D bases in Shijiazhuang, Shanghai, Beijing and the United States.